| [1] |
赵辨. 中国临床皮肤病学 [M]. 南京: 江苏科技出版社, 2010: 1239.
|
| [2] |
O′Neill JF, James WD. Inherited patterned lentiginosis in blacks [J]. Arch. Derm, 1989, 125: 1231-1235.
|
| [3] |
Pacheco TR, Oreskovich N, FainGenetic P, et al. Heterogeneity in the multiple lentigines/LEOPARD/Noonan syndromes [J]. Am J Med Gen, 2004, 127A(3): 324-326.
|
| [4] |
Shellman YG, Lambert KA, Brauweiler A, et al. SASH1 is involved in an autosomal dominant lentiginous phenotype [J]. J Invest Dermatol, 2015, 135(12): 3192-3194.
|
| [5] |
Zhou D, Wei Z, Deng S, et al. SASH1 regulates melanocytetransepithelial migration through a novel Gats-SASH1- IQGAPl-E-Cadherindependent pathway [J]. Cell Signal, 2013, 25(6): 526-1538.
|
| [6] |
Xing Q, Chen X, Wang M, et al. A locus for familial generalized lentiginosis without systemic involvement maps to chromosome 4q21. 1-q22. 3 [J]. Hum Genet, 2005, 117(2-3): 154-159.
|
| [7] |
Gorlin RJ, Anderson RC, Blaw M. Multiple lentigenes syndrome [J]. Am J Dis Child, 1969, 117(6): 652-662.
|
| [8] |
Cheng YP, Chiu HY, Hsiao TL, et al. Scalp melanoma in a woman with LEOPARD syndrome: possible implication of PTPN11 signaling in melanoma pathogenesis [J]. J Am Acad Dermatol, 2013, 69(4): e186-e187.
|
| [9] |
Voron AD, Hatfeild HH, Kolkhoff RK. Multiple lentigines syndrome: case report and reviwe of the literature [J]. Am J Med, 1976, 60(3): 447-456.
|
| [10] |
Faienza MF, Giordani L, Ferraris M, et al. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link? [J]. Pediatr Cardiol, 2009, 30(7): 1012-1015.
|
| [11] |
Digilio MC, Conti E, Sarkozy A, et al. Grouping of multiple-lentigines/ LEOPARD and Noonan syndromes on the PTPN11 gene [J]. Am J Hum Genet, 2002, 71(2): 389-394.
|
| [12] |
Nemes E, Farkas K, Kocsis-Deák B, et al. Phenotypical diversity of patients with LEOPARD syndrome carrying the worldwide recurrent p. Tyr279Cys PTPN11 mutation [J]. Arch Dermatol Res, 2015, 307(10): 891-895.
|
| [13] |
Conti E, Dottorini T, Sarkozy A, et al. A Novel PTPN11 Mutation in LEOPARD Syndrome [J]. Hum Mutat, 2003, 21(6): 654.
|
| [14] |
Yoshida R, Nagai T, Hasegawa T, et al. Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome [J]. Am J Med Gen, 2004, 130A(4): 432-434.
|
| [15] |
Kalidas K, Shaw AC, Crosby AH, et al. Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11 [J]. J Hum Genet, 2005, 50(1): 21-25.
|
| [16] |
臧东杰，许星海，周城, 等. Leopard综合征一例PTPN11基因突变研究 [J]. 中华皮肤科杂志, 2015, 48(6): 429-430.
|
| [17] |
Motegi S, Yokoyama Y, Ogino S, et al. Pathogenesis of Multiple Lentigines in LEOPARD Syndrome with PTPN11 Gene Mutation [J]. Acta Derm Venereol, 2015, 95(8): 978-984.
|
| [18] |
Yu ZH, Zhang RY, Walls CD, et al. Molecular basis of gain-of- function Leopard syndrome-associated SHP2 mutations [J]. Biochemistry, 2014, 53(25): 4136·4151.
|
| [19] |
Lauriol J, Jaffre F, Kontaridis MI. The role of the protein tyrosine phosphatase SHP2 in cardiacdevelopment and disease [J]. Semin Cell Dev Biol, 2015, 37: 73-81.
|
| [20] |
Lapinski PE, Meyer MF, Feng GS, et al. Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice [J]. Dis Model Mech, 2013, 6(6): 1448-1458.
|
| [21] |
BoneRi M, Rodriguez-Martinez V, Paardekooper OJ, et al. Distinct and overlapping functions of PTPN11 genes in Zebrafish development [J]. PLoS One, 2014, 9(4): e94884.
|
| [22] |
Pandit B, Sarkozy A, Pennacchio LA, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy [J]. Nature Genet, 2007, 39(8): 1007-1012.
|
| [23] |
Martínez-Quintana E, Rodríguez-González E. LEOPARD Syndrome: Clinical Features and Gene Mutations [J]. Mol Syndromol, 2012, 3(4): 145-157.
|
| [24] |
Sarkozy A, Carta C, Moretti S, et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum [J]. Hum Mutat, 2009, 30(4): 695-702.
|
| [25] |
Koudova M, Seemanova E, Zenker M. Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence [J]. Europ J Med, Genet, 2009, 52(5): 337-340.
|
| [26] |
Amsmeier LS, Paller AS. Pigmentary anomailes in the multiple lengitines syndrome: Is it distinct from LEOPARD syndrome [J]. Pediatr Dermatle, 1996, 13(2): 100-104.
|
| [27] |
Seuanez H, Mane-Garzon F, Kolski R. Cardio-cutaneous snydrome (the ″LEOPARD″ syndrome). Review of the literature and a new family [J]. Clin Genet, 1976, 9(3): 266-276.
|
| [28] |
Martínez-Quintana E, Rodríguez-González F. Leopard syndrome: clinical features and gene mutations [J]. Mol Syndromol, 2012, 3(4): 145-157.
|
| [29] |
Zhou D, Wei Z, Deng S, et al. SASH1 regulates melanocyte transepithelial migration through a novel Gas-SASH1-IQGAPl-E- Cadherin dependent pathway [J]. Cell Signal, 2013, 25(6): 1526-1538.
|
| [30] |
Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome [J]. Nature Genet, 2001, 29(4): 465-468.
|
| [31] |
Rodriguez-Viciana P, Tetsu O, Tidyman WE, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome [J]. Science, 2006, 311(5765): 1287-1290.
|
| [32] |
Bezniakow N, Gos M, Obersztyn E. The RASopathies as an example of RAS/MAPK pathway disturbances-clinical presentation and molecular pathogenesis of selected syndromes [J]. Dev Pedod Med, 2014, 18(3): 285-296.
|
| [33] |
Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes [J]. Fam Cancer, 2011, 10(3): 481-490.
|